|
# |
Article Title |
Date |
Author |
Hits |
|
181 |
Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
|
Monday, 15 November 2010 |
ClinicalTrial.gov |
104 |
|
182 |
Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis
|
Monday, 15 November 2010 |
ClinicalTrial.gov |
55 |
|
183 |
Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
|
Monday, 15 November 2010 |
ClinicalTrial.gov |
- |
|
184 |
Biomarkers and Knee Osteoarthritis
|
Friday, 12 November 2010 |
ClinicalTrial.gov |
64 |
|
185 |
Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)
|
Thursday, 04 November 2010 |
ClinicalTrial.gov |
67 |
|
186 |
Post-Approval Study to Investigate the Long Term (8 Year) Survivorship of STAR Ankle Among Continued Access Study Patients
|
Thursday, 04 November 2010 |
ClinicalTrial.gov |
76 |
|
187 |
Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)
|
Thursday, 04 November 2010 |
ClinicalTrial.gov |
- |
|
188 |
Post-Approval Study to Investigate the Long Term (8 Year) Survivorship of STAR Ankle Among Continued Access Study Patients
|
Thursday, 04 November 2010 |
ClinicalTrial.gov |
- |
|
189 |
2-Year Post-Approval Study to Investigate the Scandinavian Total Ankle Replacement System (STAR) Ankle Under Actual Conditions of Use
|
Tuesday, 02 November 2010 |
ClinicalTrial.gov |
70 |
|
190 |
2-Year Post-Approval Study to Investigate the Scandinavian Total Ankle Replacement System (STAR) Ankle Under Actual Conditions of Use
|
Tuesday, 02 November 2010 |
ClinicalTrial.gov |
- |
|
191 |
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
|
Monday, 01 November 2010 |
ClinicalTrial.gov |
113 |
|
192 |
A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)
|
Thursday, 28 October 2010 |
ClinicalTrial.gov |
87 |
|
193 |
A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)
|
Thursday, 28 October 2010 |
ClinicalTrial.gov |
- |
|
194 |
Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan)
|
Wednesday, 27 October 2010 |
ClinicalTrial.gov |
60 |
|
195 |
Influence of Oxidative Dysbalance on Secondary Osteoarthritis
|
Monday, 25 October 2010 |
ClinicalTrial.gov |
58 |
|
196 |
Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis
|
Friday, 22 October 2010 |
ClinicalTrial.gov |
99 |
|
197 |
A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) (ALABASTER)
|
Friday, 15 October 2010 |
ClinicalTrial.gov |
47 |
|
198 |
A Study of Glucocorticoid Use to Evaluate Systematic Methylprednisolone Reduction in Patients With Rheumatoid Arthritis on Background RoActemra/Actemra (Tocilizumab) (ACT-ALONE)
|
Monday, 11 October 2010 |
ClinicalTrial.gov |
44 |
|
199 |
Assessment of the Effects of Chondroitin Sulphate in Patients With Knee Osteoarthritis With Functional Magnetic Resonance Imaging (fMRI)
|
Friday, 08 October 2010 |
ClinicalTrial.gov |
52 |
|
200 |
An Open Label Study for Patients With Rheumatoid Arthritis
|
Tuesday, 05 October 2010 |
ClinicalTrial.gov |
77 |